TwinStrand Biosciences Announces $50M Series B
Gene-sequencing startup TwinStrand Biosciences raises $50M Series B
Updates
Current Health Raises $43M Series B
Current Health, a remote healthcare platform, raises $43M Series B
C2i Genomics Raises $100M Series B
C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B
Meatable raises $47M Series A
Congrats to Meatable, we are excited to build a sustainable future!
Evidation Health announces $153M Series E funding round
Evidation Raises $153M to Scale Virtual Health Capabilities of Achievement™ Platform
Thank you to our managing partner, Dr. Mike Pellini, for all of his hard work with The Rockefeller Foundation to safely reopen our schools.
Biden Administration commits to fully funding The Rockefeller Foundation’s plan to reopen schools.
Welcoming two new leaders to the team
Today, we are happy to announce two key hires to support our continued growth: Andy Harrison as Managing Partner and Sue Hager as Chief Investor Relations and Communications Officer.
Yes, startup valuations are rising like crazy, but here’s the reason it’s not as dramatic as it looks.
Last week, The Information published an article pointing out the “crazy” rise of startup valuation since the last Global Financial Crisis ended in 2009.
